The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys.

Administration of either low or high doses of the alpha-2A adrenergic agonist guanfacine (GFC) to aged monkeys has been shown to improve performance of the delayed-response task, a task linked to the dorsolateral prefrontal cortex (dlPFC). Monkeys treated with higher guanfacine doses also appeared less disinhibited, suggesting enhanced ventromedial-orbital PFC (vmPFC) function. To test this hypothesis, the current study examined the effects of low versus high doses of GFC on reversal of a visual object discrimination task, a task particularly sensitive to vmPFC lesions. The results of this study showed that high (0.1 mg/kg) but not low (0.00001-0.001 mg/kg) doses of GFC significantly improved reversal performance in aged monkeys. These results may be relevant to GFC's calming effects in attention deficit hyperactivity disorder.

[1]  H. Shenkin,et al.  THE RELATION OF AREA 13 ON ORBITAL SURFACE OF FRONTAL LOBES TO HYPERACTIVITY AND HYPERPHAGIA IN MONKEYS , 1943 .

[2]  C. Butter,et al.  Perseveration of responding and nonresponding in monkeys with orbital frontal ablations. , 1969, Journal of comparative and physiological psychology.

[3]  Charles M. Butter,et al.  Perseveration in extinction and in discrimination reversal tasks following selective frontal ablations in Macaca mulatta , 1969 .

[4]  Mortimer Mishkin,et al.  A re-examination of the effects of frontal lesions on object alternation , 1969 .

[5]  D. R. Snyder,et al.  Effects of orbital frontal lesions on aversive and aggressive behaviors in rhesus monkeys. , 1970, Journal of comparative and physiological psychology.

[6]  M. Oscar-Berman.  The effects of dorsolateral-frontal and ventrolateral-orbitofrontal lesions on nonspatial test performance , 1978, Neuropsychologia.

[7]  R. Bartus,et al.  Aging in the rhesus monkey: effects on visual discrimination learning and reversal learning. , 1979, Journal of gerontology.

[8]  A. Luria.  Higher Cortical Functions in Man , 1980, Springer US.

[9]  D. F. Benson,et al.  Evidence for involvement of orbitofrontal cortex in memory functions: An interference effect. , 1982 .

[10]  D. Bylund.  Heterogeneity of alpha-2 adrenergic receptors , 1985, Pharmacology Biochemistry and Behavior.

[11]  P. Goldman-Rakic,et al.  Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. , 1985, Science.

[12]  B. Mishara,et al.  Drugs and Aging , 1987 .

[13]  V. Mountcastle,et al.  Higher functions of the brain , 1987 .

[14]  F. Leslie,et al.  Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[15]  M. Caron,et al.  Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. , 1987, Science.

[16]  M. Caron,et al.  Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Goldman-Rakic,et al.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  H. Motulsky,et al.  [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. , 1989, Molecular pharmacology.

[19]  M. Lazdunski,et al.  Guanabenz, guanochlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes. , 1989, European journal of pharmacology.

[20]  P. Goldman-Rakic,et al.  Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeys , 1990, Neurobiology of Aging.

[21]  P. O’Connell,et al.  Clonidine in child and adolescent psychiatry. , 1990, Journal of child and adolescent psychopharmacology.

[22]  M. Caron,et al.  Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Spedding,et al.  α2‐Adrenoceptor subtypes and imidazoline‐like binding sites in the rat brain , 1990 .

[24]  Visual discrimination and reversal learning in the aged monkey (Macaca mulatta). , 1990, Behavioral neuroscience.

[25]  S. Foote,et al.  Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  W. J. Jackson,et al.  Clonidine enhances delayed matching-to-sample performance by young and aged monkeys , 1991, Pharmacology Biochemistry and Behavior.

[27]  J. Wikberg,et al.  Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radiollgand binding: computer modelling reveals that guanfacine is an α2A-selective compound , 1991 .

[28]  György Buzsáki,et al.  Noradrenergic Control of Thalamic Oscillation: the Role of α‐2 Receptors , 1991 .

[29]  A. Arnsten,et al.  Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype , 1991, Neuropharmacology.

[30]  Laurie A. Miller,et al.  Impulsivity, risk-taking, and the ability to synthesize fragmented information after frontal lobectomy , 1992, Neuropsychologia.

[31]  C. Geula,et al.  Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey , 1992, The Journal of comparative neurology.

[32]  J. Cai,et al.  Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine , 1993, Brain Research.

[33]  R. Ridley,et al.  Cognitive inflexibility after archicortical and paleocortical prefrontal lesions in marmosets , 1993, Brain Research.

[34]  Bao-Ming Li,et al.  Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. , 1994, Behavioral and neural biology.

[35]  J. Coull.  Pharmacological Manipulations of the α2-Noradrenergic System , 1994 .

[36]  R. Schultz,et al.  Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  R. D. Hunt,et al.  An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  L. J. Barnhill,et al.  Guanfacine for Treatment of Attention-Deficit Hyperactivity Disorder in Boys , 1995 .

[39]  P. Goldman-Rakic,et al.  Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  H. Tanila,et al.  The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats , 1996, Brain Research Bulletin.

[41]  S. Foote,et al.  Modulation of Forebrain Electroencephalographic Activity in Halothane-Anesthetized Rat via Actions of Noradrenergic β-Receptors within the Medial Septal Region , 1996, The Journal of Neuroscience.

[42]  S. Foote,et al.  Enhancement of Behavioral and Electroencephalographic Indices of Waking following Stimulation of Noradrenergic β-Receptors within the Medial Septal Region of the Basal Forebrain , 1996, The Journal of Neuroscience.

[43]  T. Robbins,et al.  Dissociation in prefrontal cortex of affective and attentional shifts , 1996, Nature.

[44]  R. D. Hunt,et al.  The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .

[45]  E. Bullmore,et al.  Society for Neuroscience Abstracts , 1997 .

[46]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[47]  A. Arnsten,et al.  The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys , 1997, Neurobiology of Aging.